Loading
companiesCompany
Galderma
Galderma is a Swiss dermatology company, listed in 2024, whose cancer-related trials concern photodynamic therapy for actinic keratosis and basal cell carcinoma.
Also called: Galderma R&DGalderma S.A.Spirig Pharma Ltd.Spirig Pharma
Overview
Galderma, based in Zug and listed on the SIX Swiss Exchange since 2024, is a dermatology company spanning prescription medicines, aesthetics and consumer skin care. Its cancer-related registry trials mostly concern methyl aminolevulinate photodynamic therapy (Metvix) for actinic keratosis and superficial basal cell carcinoma. OnCo records it so that those phase 3 trials resolve to a sponsor page.
Headquarters
Zug, CH
Scorecard
All companies#299of 1244 companies, score 14
- modalities +2
- regions +1
- registry trials +11
0 approved, 0 in phase 3, 0 earlier, 0 targets, 31 registry studies. Formula on the scorecards page.
Type
Stage
Public
Website
EstablishedTopical photosensitiser cream for photodynamic therapy
Methyl aminolevulinate · Metvix / Metvixia
Methyl aminolevulinate is a cream applied to sun-damaged skin or a superficial basal cell carcinoma and then activated with red light, clearing precancerous and early skin cancers with better cosmetic results than surgery or freezing.
Similar pages
- TrialPhotodynamic therapy against surgery for nodular basal cell carcinoma
Shares Methyl aminolevulinate, Photodynamic therapy lasers and light sources, Basal cell carcinoma.
- TrialPhotodynamic therapy against cryotherapy for superficial basal cell carcinoma
Shares Methyl aminolevulinate, Photodynamic therapy lasers and light sources, Basal cell carcinoma.
- TrialSafety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
- TrialPhotodynamic therapy against imiquimod against fluorouracil for superficial basal cell carcinoma
Shares Methyl aminolevulinate, Photodynamic therapy lasers and light sources, Basal cell carcinoma.
- InstitutionBritish Association of Dermatologists
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma.
- PersonNick Levell
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma.
- TrialFlash Radiotherapy for Skin Cancer
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma.
- InstitutionSkcin (the Karen Clifford Skin Cancer Charity)
Shares Cutaneous squamous cell carcinoma, Basal cell carcinoma.
cancers
fronts
technologies
drugs
EstablishedTopical photosensitiser cream for photodynamic therapy
Methyl aminolevulinate · Metvix / Metvixia